Viscosupplementation Market Projected to Reach USD 15.26 Billion By 2034, Growing at a CAGR of 10.1%

The global Viscosupplementation market size was valued at USD 5.81 billion in 2024 and is anticipated to generate an estimated revenue of USD 15.26 billion by 2034 , according to the latest study by Polaris Market Research. The report also notes that the market exhibits a robust Compound Annual Growth Rate (CAGR) of 10.1% over the forecast period from 2025 to 2034 .

• Rising Prevalence of Osteoarthritis: Increasing incidence of osteoarthritis globally, particularly among the aging population, is driving demand for viscosupplementation as a non-surgical treatment option.
• Growing Preference for Minimally Invasive Procedures: Patients and healthcare providers are increasingly opting for minimally invasive therapies like viscosupplementation injections to manage joint pain and improve mobility.
• Advancements in Hyaluronic Acid (HA) Formulations: Development of cross-linked and highly purified HA-based products has enhanced the efficacy and duration of viscosupplementation treatments.
• Expansion of Indications Beyond Knee Osteoarthritis: Clinical research is exploring the use of viscosupplementation for other joints such as hips, shoulders, and small joints, which could broaden market opportunities.
• Increasing Geriatric Population: With life expectancy on the rise globally, the number of individuals suffering from degenerative joint diseases is growing, boosting the adoption of viscosupplementation therapies.

• Market size value in 2025 – USD 6.39 billion
• Revenue forecast in 2034 – USD 15.26 billion
• CAGR – 10.1% from 2025 – 2034

Viscosupplementation involves the injection of hyaluronic acid (HA) into the synovial fluid of affected joints to restore its viscoelastic properties, reduce pain, and improve joint function. It is primarily used in the management of osteoarthritis, especially in the knee. The market is witnessing steady growth due to rising awareness about regenerative medicine, increasing healthcare expenditure, and the expanding application of viscosupplements in orthopedics and sports medicine. Technological advancements, coupled with favorable reimbursement policies in developed regions, are further contributing to market expansion.

https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/request-for-sample 

• Growing Incidence of Joint Disorders and Arthritis: Rising prevalence of osteoarthritis and rheumatoid arthritis, especially in aging populations, is fueling demand for effective therapeutic options like viscosupplementation.
• Increasing Adoption of Regenerative Therapies: The shift toward regenerative and biologic therapies for chronic musculoskeletal conditions is boosting the uptake of HA-based viscosupplements.
• Technological Innovations in Injectable Formulations: Introduction of longer-lasting, cross-linked HA formulations and combination therapies is improving patient compliance and treatment outcomes.
• Rising Sports Injuries and Orthopedic Conditions: The surge in sports-related injuries and musculoskeletal disorders is creating new avenues for viscosupplementation usage.
• Favorable Reimbursement Policies in Developed Regions: Enhanced insurance coverage and reimbursement for viscosupplementation procedures in North America and Europe are supporting market growth.

• Stringent Regulatory Requirements: Approval processes for viscosupplement products are rigorous, requiring extensive clinical trials and documentation, which can delay product launches.
• High Cost of Treatment: Viscosupplementation therapy can be expensive, limiting access in price-sensitive markets and low-income patient groups.
• Variable Efficacy and Clinical Evidence: Some studies question the long-term effectiveness of HA injections, leading to skepticism among physicians and payers.
• Limited Awareness in Developing Countries: Lack of awareness and inadequate healthcare infrastructure in emerging economies hinder widespread adoption of viscosupplementation.
• Competition from Alternative Therapies: The market faces competition from other treatment modalities such as corticosteroid injections, platelet-rich plasma (PRP), and surgical interventions like joint replacement.